Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients-Reference-Cited by-同舟云学术

Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients

Published:2010-11-01 Issue:11 Volume:120 Page:3843-3854
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Glynn Sharon A.,Boersma Brenda J.,Dorsey Tiffany H.,Yi Ming,Yfantis Harris G.,Ridnour Lisa A.,Martin Damali N.,Switzer Christopher H.,Hudson Robert S.,Wink David A.,Lee Dong H.,Stephens Robert M.,Ambs Stefan

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference79 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2. Prognostic effect of estrogen receptor status across age in primary breast cancer

3. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

4. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NO- and H2S- releasing nanomaterials: A crosstalk signaling pathway in cancer;Nitric Oxide;2024-10

2. Design and synthesis new indole-based aromatase/iNOS inhibitors with apoptotic antiproliferative activity;Frontiers in Chemistry;2024-09-06

3. The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Facile Synthesis of Hemin Derivatives with Modulated Aggregation Behaviour and Enhanced Nitric‐Oxide Scavenging Properties as New Therapeutics for Breast Cancer;Small Science;2024-07-16

5. Pathological and Biological Significance of the Specific Glycan, TRA-1-60, on Aggressive Gastric Adenocarcinoma;Laboratory Investigation;2024-07